##### 7.6.1.3.1 Schedule for a randomized cancer prevention trial

|     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Treatment 1st - 3rd Years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Reg | Rand | Months |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  | 3 | 6 | 9 | 12 | 18 | 24 | 30 | 36 | 42 | 48 | 54 | 60 | 66 | 72 | 78 | 84 |
| Disease Staging | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| H & P | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Assess Adverse Events and Outcome Variables | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| Chest PAL X-ray | X |  |  | X | X | X | X | X | X | X | X | X | X | X | X | X | X | X |
| CBC, Diff, Plt | X |  |  | X | X | X | X | X | X | X |  | X |  | X |  | X |  | X |
| SMA 12 | X |  | X | X | X | X | X | X | X | X |  | X |  | X |  | X |  | X |
| Cholesterol and Triglyceride | X |  | X | X | X | X | X | X | X | X |  |  |  |  |  |  |  |  |
| Electrolytes | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Plasma Retinoic Acid | X | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Cotinine Level (nonsmokers) |  | X |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
